Literature DB >> 20361852

Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.

R Calderón, S Estrada, P Ramírez de la Piscina, M Salvador, S Zabaleta, C Enciso, E Delgado, F García-Campos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20361852

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


× No keyword cloud information.
  3 in total

Review 1.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

2.  Effect of infliximab on inflammatory bowel disease with Takayasu arteritis: case series and review of the literature.

Authors:  Naoki Minami; Hiroshi Nakase; Takuya Yoshino; Satoshi Yamada; Takahiko Toyonaga; Yusuke Honzawa; Minoru Matsuura; Tsutomu Chiba
Journal:  Clin J Gastroenterol       Date:  2013-05-10

Review 3.  Takayasu arteritis in an adolescent with Crohn's disease.

Authors:  Lampros Fotis; Afroditi Kourti; Spyridon Prountzos; Efthymia Alexopoulou; Vasiliki Papaevangelou; Smaragdi Fessatou
Journal:  Rheumatol Int       Date:  2021-04-27       Impact factor: 2.631
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.